menu
    • menu

    Company profile for Acrotech Biopharma

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2018, Acrotech Biopharma LLC, was formed as a global platform to commercialize innovative proprietary medications. The company aims to launch scientifically advanced products to address unmet needs and deliver value to patients as well as all healthcare stakeholders. Acrotech aspires to be a patient focused, research-based organization that strives to launch treatments which are accessible to patients that need them...
    Founded in 2018, Acrotech Biopharma LLC, was formed as a global platform to commercialize innovative proprietary medications. The company aims to launch scientifically advanced products to address unmet needs and deliver value to patients as well as all healthcare stakeholders. Acrotech aspires to be a patient focused, research-based organization that strives to launch treatments which are accessible to patients that need them. We put our passion to work for healthier communities around the world. Our Social Impact Report shares details on how we’re doing it—this includes providing affordable medicines, collaborating with patient groups

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Acrotech BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    279 Princeton Hightstown Rd., East Windsor, NJ 08520 (866) 850-2876
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://acrotechbiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acrotech-biopharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acrotech Biopharma’s Adquey Receives Approval in US
    Acrotech Biopharma’s Adquey Receives Approval in US

    12 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219474

    FDA
    12 Feb 2026
    Share Share
    Casi Pharma Provides Business and Clinical Update
    Casi Pharma Provides Business and Clinical Update

    19 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/casi-pharmaceuticals-provides-business-and-clinical-update-1028949

    ACCESSWIRE
    19 May 2025
    Share Share
    CASI Pharmaceuticals to Divest Assets in China
    CASI Pharmaceuticals to Divest Assets in China

    12 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/casi-pharmaceuticals-enters-into-definitive-agreement-for-the-divesti-1026311

    ACCESSWIRE
    12 May 2025
    Share Share
    FDA panel urges Acrotech to speed up study on cancer drugs
    FDA panel urges Acrotech to speed up study on cancer drugs

    16 Nov 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/fda-panel-urges-acrotech-speed-up-study-cancer-drugs-2023-11-16/

    REUTERS
    16 Nov 2023
    Share Share
    Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US
    Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US

    24 Nov 2022

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/evive-enters-license-agreement-with-acrotech-biopharma-to-commercialize-ryzneuta-in-us-13335

    INDIANPHARMAPOST
    24 Nov 2022
    Share Share
    FDA's ODAC to review accelerated approvals for multiple myeloma, leukemia
    FDA's ODAC to review accelerated approvals for multiple myeloma, leukemia

    24 Sep 2021

    // Z. Brennan ENDPTS

    https://endpts.com/fdas-cancer-drug-advisors-will-review-2-more-dangling-accelerated-approvals-for-multiple-myeloma-leukemia/

    Z. Brennan ENDPTS
    24 Sep 2021
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search